NervGen Pharma Corp. (NGEN) Tops Q1 EPS by 6c

May 18, 2026 4:43 PM EDT

NervGen Pharma Corp. (NASDAQ: NGEN) reported Q1 EPS of ($0.02), $0.06 better than the analyst estimate of ($0.08).

For earnings history and earnings-related data on NervGen Pharma Corp. (NGEN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK